TAKEDA PHARMACEUTICAL COMPANY LIMITED

(4502)
  Report
Delayed Japan Exchange  -  05/26 12:41:11 am EDT
3759.00 JPY   -0.74%
05/12Japan Index Ends in Red; Toyota Clocks Record-High FY22 Attributable Income but Projects Decline Next Fiscal
MT
05/11Takeda Pharmaceutical's FY22 Attributable Profit Falls 39%
MT
05/11GLOBAL MARKETS LIVE : Coinbase, Roblox, Apple, EA, Hasbro...
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on TAKEDA PHARMACEUTICAL COMPANY LIMITED
Target Price consensus revisions : last 18 months
Recommendations (Chart) TAKEDA PHARMACEUTICAL COMPANY LIMITED
Analyst Recommendations on TAKEDA PHARMACEUTICAL COMPANY LIMITED
2021TAKEDA PHARMACEUTICAL : Morgan Stanley Downgrades Takeda Pharmaceutical to Equal-weight From Overweight
MT
2020TAKEDA PHARMACEUTICAL : Japan's Takeda says drug pipeline to lift sales to $48 billion in next decade
RE
2018Takeda clears key hurdle as investors back $59 billion Shire deal
RE
2018Takeda investors back $59 billion Shire deal, but wary of debt load
RE
2018Takeda shareholders bin proposal from anti-Shire group; only 10 percent in favour
RE
2018Takeda shareholders bin proposal from anti-Shire group; only 10 percent in favor
RE
2018Japan's Takeda clinches £45.3 billion Shire deal as pharma M&A rolls on
RE
More recommendations
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Last Close Price 3 797,00 JPY
Average target price 4 402,67 JPY
Spread / Average Target 16,0%
High Price Target 6 500,00 JPY
Spread / Highest target 71,2%
Low Price Target 3 400,00 JPY
Spread / Lowest Target -10,5%
Consensus detail
Consensus revision (last 18 months)